At the interface between these circulating factors and insulin/glucagon secretion are GPCRs, which in islets mediate the effects of many of the circulating factors, such as glucagon-like peptide-1 ...

GPCRs are the targets for around one third of ... clinical candidates and 25+ preclinical programmes in neurology, GI and immunology, and metabolic disorders — and continues to partner ...

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily ...